Toremifene Citrate Tablet
Product Images NDC 64980-404

4 FDA label images from Rising Pharma Holdings, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Toremifene Citrate (NDC 64980-404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Table 1.jpg (Table 1)

Table 1.jpg (Table 1)
A data table presenting adverse reactions across different regions (North American, Eastern European, Nordic) for the drug toremifene citrate. The table details occurrences of cardiac, ocular, thromboembolic events, and elevated liver tests, with frequencies and percentages for various subcategories such as cardiac failure, cataracts, pulmonary embolism, and liver enzymes AST and Alkaline Phosphatase in study groups identified as TOR60, TAM20, TAM40, and others.*
FDA Label Image

Structure.jpg (Structure)

Structure.jpg (Structure)
Chemical structure diagram showing two molecular structures labeled as toremifene citrate. The structures depict the arrangement of atoms and bonds in the active ingredient molecule.*
FDA Label Image

Table 2.jpg (Table 2)

Table 2.jpg (Table 2)
A data table titled Clinical Studies comparing treatment groups across North American, Eastern European, and Nordic populations. It details patient numbers, responses (complete and partial), response rates with confidence intervals, median time to progression (months), hazard ratios, and median survival times with corresponding statistical data.*
FDA Label Image

Label.jpg (Label)

Label.jpg (Label)
Label for Toremifene Citrate Tablets 60 mg by Rising Pharmaceuticals. The label includes the NDC 64980-404-03, specifies 30 tablets per container, and indicates the product is prescription only (Rx only). The label also shows storage instructions and manufacturing information for Rising Pharma Holdings, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.